Spis treści:
reklama
4. PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ
przewiń, aby zobaczyć całą tabelę
| KOMISJA NADZORU FINANSOWEGO | ||||||||||||
| Raport bieżący nr | 8 | / | 2020 | |||||||||
| Data sporządzenia: | 2020-02-25 | |||||||||||
| Skrócona nazwa emitenta | ||||||||||||
| MILESTONE MEDICAL | ||||||||||||
| Temat | ||||||||||||
| The Update on The Partnership with RedOne Medical | ||||||||||||
| Podstawa prawna | ||||||||||||
| Art. 17 ust. 1 MAR - informacje poufne. | ||||||||||||
| Treść raportu: | ||||||||||||
| The Board of Directors of Milestone Medical Inc. (WAR: MMD, “the Company”, “the Issuer”), today provided an update on its partnership with RedOne Medical, a leading medical device distributor and wholesaler serving the Department of Veterans Affairs (VA) medical centers and the Department of Defense (DoD) hospitals, to distribute the CompuFlo Epidural System. As previously announced on December 13, 2019, Milestone Medical announced that it was partnering with RedOne Medical. The Company fully intends to move forward with this relationship; however, the formal initiation of the partnership has been delayed due to specific government requirements with respect to components originated from, but purchased outside, the People’s Republic of China. The Board of Directors of the Issuer expects to be in a position to comply with such requirements in the near future. Although the rollout of our CompuFlo Epidural System with RedOne was delayed due to factors outside the control of the Issuer, The Board of Directors of the Company remains excited about the collaboration and opportunity to deploy the CompuFlo Epidural System within Department of Veterans Affairs medical centers and Department of Defense hospitals, both of which represent a significant market opportunity for the Company. The Board of Directors of the Issuer looks forward to providing further updates as developments unfold. |
||||||||||||
przewiń, aby zobaczyć całą tabelę
| MESSAGE (ENGLISH VERSION) | |||
INFORMACJE O PODMIOCIE >>>
przewiń, aby zobaczyć całą tabelę
| MILESTONE MEDICAL INC | ||||||||||||||||
| (pełna nazwa emitenta) | ||||||||||||||||
| MILESTONE MEDICAL | ||||||||||||||||
| (skrócona nazwa emitenta) | (sektor wg. klasyfikacji GPW w W-wie) | |||||||||||||||
| NJ 07039 | . | |||||||||||||||
| (kod pocztowy) | (miejscowość) | |||||||||||||||
| South Orange Avenue Livingston | 220 | |||||||||||||||
| (ulica) | (numer) | |||||||||||||||
| +11 973 535 2717 | +11 973 535 2829 | |||||||||||||||
| (telefon) | (fax) | |||||||||||||||
| (e-mail) | (www) | |||||||||||||||
| 27-5484393 | ||||||||||||||||
| (NIP) | (REGON) | |||||||||||||||
przewiń, aby zobaczyć całą tabelę
| PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ | |||||
| Data | Imię i Nazwisko | Stanowisko/Funkcja | Podpis | ||
| 2020-02-25 | Joseph D'Agostino | Chief Financial Officer | Joseph D'Agostino | ||